John Patrick Darby, EVP and general counsel of Encompass Health Corporation (NYSE:EHC), sold 8,906 shares of common stock on August 10, according to an SEC Form 4 filing.
Transaction summary
Transaction value based on SEC Form 4 weighted average sale price ($125.95); post-transaction value based on the August 10 market close ($125.81).
Key questions
How does this sale impact the executive’s overall equity exposure?
The disposal of 8,906 shares accounted for 11% of the insider’s direct common stock position, resulting in a remaining direct stake of 75,041 shares.What was the execution range for the reported transaction?
The shares were sold in multiple transactions at prices ranging from $125.94 to $126.04, yielding a weighted average price of $125.95.What is the financial profile of Encompass Health at the time of this trade?
The company, a provider of post-acute healthcare services, reported $6.2 billion in trailing-twelve-month revenue and $621.0 million in net income, supporting a market capitalization of $12.5 billion as of the August 10 market close.Does the insider maintain other forms of beneficial ownership?
Total beneficial ownership is reported at 75,041 shares, which align with the executive’s direct common stock holdings following this transaction.
Company Overview
Company Snapshot
Encompass Health Corporation operates a diversified post-acute healthcare platform delivering inpatient rehabilitation services and home health and hospice care across the United States through both dedicated facilities and in-home settings.
The company generates revenue through its two primary divisions: Inpatient Rehabilitation, which provides focused recovery treatment on an inpatient and outpatient basis, and Home Health and Hospice, which delivers care services directly to patients in their residences.
Encompass Health serves patients transitioning from acute care settings, including those recovering from significant illnesses, surgeries, and injuries, with a customer base comprised of healthcare systems, insurance providers, and individual patients requiring post-acute care services.
Encompass Health Corporation is a leading operator in the post-acute healthcare sector, with a market capitalization of $12.5 billion and TTM revenues of $6.2 billion, positioning it as a significant provider of rehabilitation and home-based care services. The company’s diversified business model across inpatient facilities and home health services provides revenue stability and exposure to the growing demand for post-acute care driven by an aging population and the shift toward value-based care delivery. With over 42,000 employees and a strong net income margin of approximately 10% on TTM revenues, Encompass Health maintains operational scale and profitability in a fragmented market characterized by consolidation opportunities.
